drugset / Trial / NCT00038025

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

NCT00038025

Phase 2 Completed 60 enrolled M.D. Anderson Cancer Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the side effects and antitumor response of patients with lymphoid malignancies to Deoxycoformycin (DCF)/Pentostatin.

Timeline

Start
1994-09-06
Primary completion
2006-11-29
Completion
2006-11-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentostatin Small molecule Intravenous